Dr Rebecca Bickner, PHARMD | |
3711 S Taylor Dr, Sheboygan, WI 53081-8495 | |
(920) 459-8601 | |
Not Available |
Full Name | Dr Rebecca Bickner |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3711 S Taylor Dr, Sheboygan, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265034672 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 16895-40 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rebecca Bickner, PHARMD 3711 S Taylor Dr, Sheboygan, WI 53081-8495 Ph: () - | Dr Rebecca Bickner, PHARMD 3711 S Taylor Dr, Sheboygan, WI 53081-8495 Ph: (920) 459-8601 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Like the strings on a violin or the pipes of an organ, the proteins in the human body vibrate in different patterns, scientists have long suspected.
A new genetic cause of corneal dystrophy has been discovered with funding from Fight for Sight by researchers at UCL Institute of Ophthalmology and Moorfields Eye Hospital London, in collaboration with colleagues in the Czech Republic.
Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem in mind, Fox Chase Cancer Center researchers are testing a novel type of antibody called MM-111 in patients with HER2-positive disease who have progressed on standard therapy.
In a new study published in Nature Communications, researchers at Karolinska Institutet show that MAIT cells (mucosa-associated invariant T cells), part of the human immune system, respond with dynamic activity and reprogramming of gene expression during the initial phase of HIV infection.
› Verified 1 days ago
Mr. Lawrence J Mihalevich, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 | |
Mary Miller, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1317 N 25th St, Picknsave Pharmacy 6432, Sheboygan, WI 53081 Phone: 920-457-5839 Fax: 920-457-5853 | |
Christa Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 Saemann Ave, Sheboygan, WI 53081 Phone: 920-783-6633 | |
Judith L Lukach, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Matthew Wilke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Dr. David Roth, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 N 14th St, Sheboygan, WI 53081 Phone: 920-452-0079 | |
Tou Lee Xiong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 |